The fluorescent two-hybrid assay to screen for protein-protein interaction inhibitors in live cells: targeting the interaction of p53 with Mdm2 and Mdm4
- PMID: 24476585
- DOI: 10.1177/1087057113518067
The fluorescent two-hybrid assay to screen for protein-protein interaction inhibitors in live cells: targeting the interaction of p53 with Mdm2 and Mdm4
Abstract
Protein-protein interactions (PPIs) are attractive but challenging targets for drug discovery. To overcome numerous limitations of the currently available cell-based PPI assays, we have recently established a fully reversible microscopy-assisted fluorescent two-hybrid (F2H) assay. The F2H assay offers a fast and straightforward readout: an interaction-dependent co-localization of two distinguishable fluorescent signals at a defined spot in the nucleus of mammalian cells. We developed two reversible F2H assays for the interactions between the tumor suppressor p53 and its negative regulators, Mdm2 and Mdm4. We then performed a pilot F2H screen with a subset of compounds, including small molecules (such as Nutlin-3) and stapled peptides. We identified five cell-penetrating compounds as potent p53-Mdm2 inhibitors. However, none exhibited intracellular activity on p53-Mdm4. Live cell data generated by the F2H assays enable the characterization of stapled peptides based on their ability to penetrate cells and disrupt p53-Mdm2 interaction as well as p53-Mdm4 interaction. Here, we show that the F2H assays enable side-by-side analysis of substances' dual Mdm2-Mdm4 activity. In addition, they are suitable for testing various types of compounds (e.g., small molecules and peptidic inhibitors) and concurrently provide initial data on cellular toxicity. Furthermore, F2H assays readily allow real-time visualization of PPI dynamics in living cells.
Keywords: Fluorescent two-hybrid (F2H) assay; Hdm2; HdmX; Mdm2; Mdm4; p53; protein–protein interaction screen.
Similar articles
-
A yeast two-hybrid system for the screening and characterization of small-molecule inhibitors of protein-protein interactions identifies a novel putative Mdm2-binding site in p53.BMC Biol. 2017 Nov 9;15(1):108. doi: 10.1186/s12915-017-0446-7. BMC Biol. 2017. PMID: 29121928 Free PMC article.
-
Targeting the MDM2/MDM4 interaction interface as a promising approach for p53 reactivation therapy.Cancer Res. 2015 Nov 1;75(21):4560-72. doi: 10.1158/0008-5472.CAN-15-0439. Epub 2015 Sep 10. Cancer Res. 2015. PMID: 26359458
-
Implementation of a 220,000-compound HCS campaign to identify disruptors of the interaction between p53 and hDM2 and characterization of the confirmed hits.J Biomol Screen. 2010 Aug;15(7):766-82. doi: 10.1177/1087057110375304. Epub 2010 Jul 16. J Biomol Screen. 2010. PMID: 20639499
-
Peptides and peptidomimetics in the p53/MDM2/MDM4 circuitry - a patent review.Expert Opin Ther Pat. 2016 Dec;26(12):1417-1429. doi: 10.1080/13543776.2017.1233179. Epub 2016 Sep 20. Expert Opin Ther Pat. 2016. PMID: 27603098 Review.
-
Small-molecule inhibitors of the p53-MDM2 interaction.Curr Top Microbiol Immunol. 2011;348:151-72. doi: 10.1007/82_2010_110. Curr Top Microbiol Immunol. 2011. PMID: 21046355 Review.
Cited by
-
Protoporphyrin IX is a dual inhibitor of p53/MDM2 and p53/MDM4 interactions and induces apoptosis in B-cell chronic lymphocytic leukemia cells.Cell Death Discov. 2019 Mar 11;5:77. doi: 10.1038/s41420-019-0157-7. eCollection 2019. Cell Death Discov. 2019. PMID: 30886745 Free PMC article.
-
Reactivation of p53 by a Cytoskeletal Sensor to Control the Balance Between DNA Damage and Tumor Dissemination.J Natl Cancer Inst. 2015 Oct 13;108(1):djv289. doi: 10.1093/jnci/djv289. Print 2016 Jan. J Natl Cancer Inst. 2015. PMID: 26464464 Free PMC article.
-
Exploring Protein⁻Protein Interaction in the Study of Hormone-Dependent Cancers.Int J Mol Sci. 2018 Oct 15;19(10):3173. doi: 10.3390/ijms19103173. Int J Mol Sci. 2018. PMID: 30326622 Free PMC article. Review.
-
MDM2 Inhibitors for Cancer Therapy: The Past, Present, and Future.Pharmacol Rev. 2024 May 2;76(3):414-453. doi: 10.1124/pharmrev.123.001026. Pharmacol Rev. 2024. PMID: 38697854 Free PMC article. Review.
-
Molecular and Biochemical Techniques for Deciphering p53-MDM2 Regulatory Mechanisms.Biomolecules. 2020 Dec 30;11(1):36. doi: 10.3390/biom11010036. Biomolecules. 2020. PMID: 33396576 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous